Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Saizen is a brand-name prescription medication containing Somatropin, a recombinant human growth hormone (rhGH) manufactured by EMD Serono. It is FDA-approved for treating pediatric growth failure due to inadequate secretion of endogenous growth hormone, as well as adult growth hormone deficiency — whether childhood-onset or adult-onset due to pituitary disease, surgery, radiation therapy, or trauma.
Saizen is a subcutaneous injection that must be reconstituted from a lyophilized (freeze-dried) powder before use. It is identical in structure to the naturally occurring 191-amino acid growth hormone produced by the pituitary gland.
Saizen contains Somatropin, which is structurally identical to the growth hormone naturally produced by your pituitary gland. When injected subcutaneously, Somatropin binds to growth hormone receptors on target cells throughout the body. This triggers the liver and other tissues to produce insulin-like growth factor 1 (IGF-1), which mediates many of the growth-promoting effects.
In children, IGF-1 stimulates linear bone growth at the growth plates. In both children and adults, it promotes protein synthesis, increases fat metabolism (reducing body fat), helps maintain healthy body composition, and supports bone density. The effects build up gradually over weeks to months of consistent therapy.
Typical pediatric dosing is 0.18 mg/kg/week divided into daily or alternate-day injections. Adult starting doses are typically 0.005 mg/kg/day (weight-based) or 0.2 mg/day (non-weight-based), titrated gradually based on response and IGF-1 levels.
Saizen scores a 50 out of 100 on our findability scale, meaning it can be moderately difficult to locate. As a specialty injectable growth hormone product manufactured by EMD Serono, Saizen is distributed almost exclusively through specialty pharmacies rather than standard retail pharmacies. While it is not currently listed on the FDA drug shortage database, the specialty distribution model means you may encounter access challenges depending on your location and insurance plan. Many insurers prefer other brands like Norditropin or Omnitrope, which can create additional hurdles when trying to fill a Saizen prescription specifically. If your pharmacy doesn't carry it, Medfinder can help you locate a specialty pharmacy with Saizen in stock near you.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.
Saizen is most commonly prescribed by the following specialists:
Because Saizen requires prior authorization from most insurance plans, the prescribing physician typically needs to provide documentation of confirmed growth hormone deficiency through provocative stimulation testing. If you need help finding an endocrinologist, Medfinder can assist.
No, Saizen is not a DEA-scheduled controlled substance. However, Somatropin is regulated under federal law and requires a valid prescription. It is worth noting that human growth hormone is prohibited by the World Anti-Doping Agency (WADA) in competitive sports, and distributing it for anti-aging or athletic performance enhancement purposes is illegal under federal law. Saizen is only legally prescribed for FDA-approved indications.
Most side effects are dose-related and may improve with dose adjustment. Serious but rare side effects include pancreatitis, new or worsening diabetes, intracranial hypertension, and slipped capital femoral epiphysis in children. Contact your doctor immediately if you experience severe stomach pain, vision changes, or hip/knee pain with limping.
Several other Somatropin products are available if Saizen is difficult to find or not covered by your insurance:
All of these contain Somatropin and work the same way. The main differences are in delivery devices, reconstitution requirements, and insurance coverage. Ask your endocrinologist and check with your insurer to find the best option for your situation.
Always inform your doctor about all medications, supplements, and vitamins you are taking before starting Saizen therapy.
Saizen is an effective and well-established recombinant growth hormone treatment for both pediatric and adult growth hormone deficiency. However, it can be challenging to access due to specialty pharmacy distribution, high costs ($700–$1,500+ per vial without insurance), and the frequent requirement for prior authorization. Many insurance plans may steer patients toward preferred alternatives like Norditropin or Omnitrope.
If you're having difficulty finding Saizen in stock or navigating the insurance approval process, Medfinder can help you locate specialty pharmacies with availability near you. For cost savings, explore EMD Serono's patient assistance programs, Prescription Hope ($70/month), or biosimilar alternatives like Omnitrope that may offer comparable treatment at a lower price.
%2C%20Color%3DOriginal.png)
